pharmaceutical investing Pfizer and Blackstone Life Sciences Announce Strategic Funding Agreement for Obesity Program
pharmaceutical investing Pfizer's ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple Myeloma
pharmaceutical investing Pfizer's TALZENNA Plus XTANDI FDA-Approved for an Earlier Metastatic Prostate Cancer Treatment Setting
pharmaceutical investing Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026
pharmaceutical investing Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026
pharmaceutical investing Pfizer's TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer
pharmaceutical investing Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026
pharmaceutical investing Pfizer's LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo
pharmaceutical investing Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study
pharmaceutical investing Pfizer Advances Today's Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
pharmaceutical investing Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts
pharmaceutical investing Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
Cerrado Gold Acquires the Past-Producing Manantial Espejo Mine in Santa Cruz, Argentina, from Pan American Silver
Triumph Gold Announces Strategic Review of Non-Core Exploration Projects and $15 Million Private Placement
